Updated on 12 January 2026
Paediatric Cancer Centre Barcelona: A Global Reference in Pediatric Oncology
Pre-Award Project Manager at Institut de Recerca Sant Joan de Déu (IRSJD)
Esplugues de Llobregat, Spain
About
The Paediatric Cancer Centre Barcelona (PCCB) of Barcelona Children’s Hospital Sant Joan de Déu, (HSJD) is the first monographic centre in Spain on childhood cancer and one of the few in Europe. Currently, it accumulates the highest number of new cases per year (>400) for the diagnosis and treatment of childhood and adolescent cancer within Spain. The PCCB-HSJD is also an international reference center, receiving >100 patients a year from outside Spain and Europe. Functional Units:
-
Leukemia, Lymphoma Histiocytosis
-
Brain and Spinal Cord Tumors
-
Extra-cranial Solid Tumors
-
Hematopoietic Progenitor Transplant Unit & CAR-T cell unit
-
Survivorship Unit
-
Cancer Predisposition Unit
More information at: https://www.sjdhospitalbarcelona.org/en/hospital/strategic-projects/pediatric-cancer-center-barcelona
Topic
- DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-03: Integrating New Approach Methodologies (NAMs) to advance biomedical research and regulatory testing
- DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-06: Support to European Research Area (ERA) action on accelerating New Approach Methodologies (NAMs) to advance biomedical research and testing of medicinal products and medical devices
- DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-07: Establishing a European network of Centres of Excellence (CoEs) for Advanced Therapies Medicinal Products (ATMPs)
Type
- Partner seeks Consortium/Coordinator
Organisation
Similar opportunities
Project cooperation
Barcelona Children’s Hospital Sant Joan de Déu: Excellence in Paediatric Care and Research
- DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-15: Scaling up innovation in cardiovascular health
- DESTINATION 1: HORIZON-HLTH-2026-01-STAYHLTH-03: Building public trust and outreach in the life sciences
- DESTINATION 4: HORIZON-HLTH-2026-01-CARE-03: Identifying and addressing low-value care in health and care systems
- DESTINATION 2: HORIZON-HLTH-2026-01-ENVHLTH-05: Support for a multilateral initiative on climate change and health research
- DESTINATION 2: HORIZON-HLTH-2026-01-ENVHLTH-04: Towards climate resilient, prepared and carbon neutral populations and healthcare systems
- DESTINATION 2: HORIZON-HLTH-2026-01-ENVHLTH-01: Towards a better understanding and anticipation of the impacts of climate change on health
- DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-03: Integrating New Approach Methodologies (NAMs) to advance biomedical research and regulatory testing
- DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-03: Advancing research on the prevention, diagnosis, and management of post-infection long-term conditions
- DESTINATION 1: HORIZON-HLTH-2026-01-STAYHLTH-02: Behavioural interventions as primary prevention for Non-Communicable Diseases (NCDs) among young people
- DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-11: Understanding of sex and/or gender-specific mechanisms of cardiovascular diseases: determinants, risk factors and pathways
- DESTINATION 4: HORIZON-HLTH-2026-01-CARE-01: Public procurement of innovative solutions for improving citizens' access to healthcare through integrated or personalised approaches
- DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-02: Innovative interventions to prevent the harmful effects of using digital technologies on the mental health of children and young adults
- DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-09: Multisectoral approach to tackle chronic non-communicable diseases: implementation research maximising collaboration and coordination with sectors and in settings beyond the healthcare system (GACD)
Anna Boronat
Pre-award project manager at Institut de Recerca Sant Joan de Déu (IRSJD)
Esplugues de Llobregat, Spain
Project cooperation
Targeted brain cancer drug development
- DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-03: Integrating New Approach Methodologies (NAMs) to advance biomedical research and regulatory testing
Jiney Jose
Senior Research Fellow at The University of Auckland
Auckland, New Zealand
Project cooperation
Computational prognosis of therapies for solid tumors
- DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-03: Integrating New Approach Methodologies (NAMs) to advance biomedical research and regulatory testing
- DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-06: Support to European Research Area (ERA) action on accelerating New Approach Methodologies (NAMs) to advance biomedical research and testing of medicinal products and medical devices
Gianpaolo Ruocco
Professor and CEO at initiatives for Bio-Materials Behavior (iBMB) Srls
Potenza, Italy